Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$2.85 - $7.77 $32,963 - $89,867
-11,566 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$5.7 - $9.3 $65,926 - $107,563
11,566 New
11,566 $88,000
Q4 2021

Feb 14, 2022

SELL
$8.73 - $15.27 $250,542 - $438,233
-28,699 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$13.52 - $23.95 $388,010 - $687,341
28,699 New
28,699 $398,000
Q2 2020

Aug 06, 2020

SELL
$13.25 - $21.72 $1.27 Million - $2.08 Million
-95,600 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$9.73 - $24.9 $930,188 - $2.38 Million
95,600 New
95,600 $1.38 Million
Q4 2018

Feb 14, 2019

SELL
$26.22 - $56.89 $148,929 - $323,135
-5,680 Closed
0 $0
Q3 2018

Oct 18, 2018

SELL
$24.31 - $52.74 $311,654 - $676,126
-12,820 Reduced 69.3%
5,680 $276,000
Q2 2018

Aug 07, 2018

BUY
$20.25 - $35.96 $374,625 - $665,260
18,500 New
18,500 $542,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.35B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.